The effect of dehydroepiandrosterone on lipogenic gene mRNA expression in cultured primary chicken hepatocytes

European Journal of Lipid Science and Technology

Volumn 111, Issue 5, 2009, Pages 432-441

  Tang, Xue ^a   Ma, Haitian ^a   Huang, Guoqing ^a   Miao, Jinfeng ^a   Zou, Sixiang ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

Author keywords

Cell survival; Cultured primary chicken hepatocytes; Dehydroepiandrosterone (DHEA); Lipogenic genes

Indexed keywords

EID: 67449123293     PISSN: 14387697     EISSN: 14389312     Source Type: Journal    
DOI: 10.1002/ejlt.200800169     Document Type: Article

References (56)

1. J. Mallard, M. Douaire: Strategies of selection for leanness in meat production. In: Leanness in Domestic Birds. Genetic, Metabolic and Hormonal Aspects. B. Leclerq and C. C. Whitehead, Butterworth-Heinemann, Oxford (UK) 1988, pp. 3-23.
2. G. Q. Wu, X. M. Deng, J. Y. Li, J. Y. Li, N. Yang:A potential molecular marker for selection against abdominal fatness in chickens.Poult Sci. 2006, 85, 1896-1899.
3. W. Leowattana: DHEA(S) the fountain of youth. J Med Assoc Thai. 2001, 84, S605-S612.
4. T. Yanase, M. Fukahori, S. Taniguchi, Y. Nishi, Y. Sakai, R. Takayanagi, M. Haji, H. Nawata: Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEA-S) in Alzheimer's disease and cerebrovascular dementia. Endocr J. 1996, 43, 119-123.
5. T. T. Yen, J. A. Allen, D. V. Pearson, J. Acton, M. M. Greenberg: Prevention of obesity in mice by dehydroepiandrosterone. Lipids. 1977, 12, 409-413.
6. A. Tagliaferro, J. R. Davis, S. Truchon, N. Van Hamont: Effect of dehydroepiandrosterone acetate on metabolism, body weight and composition of male and female rats. J Nutr. 1986, 116, 1977-1983.
7. D. H. Han, P. A. Hansen, M. M. Chen, J. O. Holloszy: DHEA treatment reduces fat accumulation and protects against insulin resistance in male rats. J Gerontol A Biol Sci Med Sci. 1998, 53, B19-B24.
8. M. Araghi-Niknam, S. K. Ardestani, P. Molitor Inserra, C. Eskelson, R. R. Watson: Dehydroepiandrosterone (DHEA) sulfate prevents reduction in tissue vitamin E and increased lipid peroxidation due to murine retrovirus infection of aged mice. Proc Soc Exp Biol Med. 1998, 218, 210-217.
9. Z. Barrou, P. Charru, C. Lidy: Dehydroepiandrosterone (DHEA) and aging. Arch Gerontol Geriatr. 1997, 4, 233-241.
10. A. Khalil, J. G. Lehoux, R. J. Wagner, O. Lesur, S. Crux, E. Dupont, J. P. Jay-Gerin, J. Wallach, T. Fulop: Dehydroepiandrosterone against copper-induced lipid peroxidation in the rat. Free Radic Biol Med. 1998, 22, 1289-1294.
11. J. Swierczynski, Z. Kochan, D. Mayer: Dietary alpha-tocopherol prevents dehydroepiandrosterone induced lipid peroxidation in rat liver microsomes and mitochondria. Toxicol Lett. 1997, 91, 129-136.
12. N. C. Yang, K. C. Jeng, W. M. Ho, M. L. Hu: ATP depletion is an important factor in DHEA-induced inhibition and apoptosis in BV-2 cells. Life Sci. 2002, 70, 1979-1988.
13. F. A. Huppert, J. K. Van Niekerk: Dehydroepiandrosterone (DHEA) supplementation for cognitive function. Cochrane Database Syst Rev. 2001, 2, CD00034.
14. A. J. Morales, R. H. Haubrich, J. Y. Hwang, H. Asakura, S. S. Yen: The effect of 6 months treatment with 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin Endocrinol. 1998, 49, 421-432.
15. J. Yamada, M. Sakuma, T. Ikeda, K. Fukuda, T. Suga: Characteristics of dehydroepiandrosterone as a peroxisome proliferator. Biochim Biophys Acta. 1991, 1092, 233-243.
16. T. Suga, H. Tamura, T. Watanabe, J. Yamada: Induction of peroxisomal enzymes by dehydroepiandrosterone metabolic activation by sulfate conjugation. Ann N Y Acad Sci. 1996, 804, 284-296.
17. M. Sakuma, J. Yamada, T. Suga: Induction of peroxisomal β oxidation by structural analogues of dehydroepiandrosterone in cultured rat hepatocytes: Structure-activity relationships. Biochim Biophys Acta. 1993, 1169, 66-72.
18. X. Tang, H. T. Ma, S. X. Zou, W. H. Chen: Effects of dehydroepiandrosterone (DHEA) on hepatic lipid metabolism parameters and lipogenic gene mRNA expression in broiler chickens. Lipids. 2007, 42, 1025-1033.
19. G. D. Pergola: The adipose tissue metabolism: Role of testosterone and dehydroepiandrosterone. Int J Obes Relat Metab. 2000, 24, S59-S63.
20. C. D. Berdanier, M. K. McIntosh: Further studies on the effects of dehydroepiandrosterone on hepatic metabolism in BHE rats. Proc Soc Exp Biol Med. 1989, 192, 242-247.
21. S. W. Kennedy, A. Lorenzen, C. A. James, B. T. Collins: Ethoxyresorufin-O-deethylase and porphyrin analysis in chicken embryo hepatocyte cultures with a fluorescent multi well plate reader. Anal Biochem. 1993, 211, 102-112.
22. rd Edn. Wiley-Liss, New York, NY (USA) 1994.
23. A. M. Glauert: Fixation, dehydration and embedding of biological specimens. In: Practical Methods in Electron Microscopy. Vol. 3. Ed. A. Glauert, Elsevier Biomedical Press, Amsterdam (The Netherlands) 1980, pp. 91.
24. I. Fidelis, F. I. Ikegwuonu, C. R. Jefcoate: Evidence for the involvement of the fatty acid and peroxisomal β-oxidation pathways in the inhibition by dehydroepiandrosterone (DHEA) and induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and benz(a)anthracene (BA) of cytochrome P4501B1 (CYP1Bl) in mouse embryo fibroblasts (C3H10T1/2 cells). Mol Cell Biochem. 1999, 198, 89-100.
25. Z. R. Xu, M. Q. Wang, H. X. Mao, X. A. Zhan, C. H. Hu: Effects of L-carnitine on growth performance, carcass composition, and metabolism of lipids in male broilers. Poult Sci. 2003, 82, 408-413.
26. S. Zhao, H. Ma, S. Zou, W. Chen: Effects of DHEA on hepatic lipogenic gene expression in broilers during embryonic development. Lipids. 2007, 42, 749-757.
27. H. Shimano, J. D. Horton, R. E. Hammer, I. Shimomura, M. S. Brown, J. L. Goldstein: Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J Clin Invest. 1996, 98, 1575-1584.
28. F. Foufelle, P. Ferre: New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: A role for the transcription factor sterol regulatory element binding protein-1c. Biochem J. 2002, 366, 377-391.
29. L. Yin, Y. Zhang, F. B. Hillgartner: Sterol regulatory elementbinding protein-1 interacts with the nuclear thyroid hormone receptor to enhance acetyl-CoA carboxylase-alpha transcription in hepatocytes. J Biol Chem. 2002, 277, 19554-19565.
30. Y. Zhang, L. Yin, F. B. Hillgartner: SREBP-1 integrates the actions of thyroid hormone, insulin, cAMP, and medium chain fatty acids on ACCalpha transcription in hepatocytes. J Lipid Res. 2003, 44, 356-368.
31. J. B. Allred, K. L. Roehrig: Inhibition of hepatic lipogenesis by cyclic-3',5'-nucleotide monophosphates. Biochem Biophys Res Commun. 1972, 46, 1135-1139.
32. D. M. Capuzzi, V. Rothman, S. Margolis: The regulation of lipogenesis by cyclic nucleotides in intact hepatocytes prepared by a simplified technique. J Biol Chem. 1974, 249, 1286-1294.
33. D. M. Tarlow, P. A. Watkins, R. E. Reed, R. S. Miller, E. E. Zwergel, M. D. Lane: Lipogenesis and the synthesis and secretion of very low density lipoprotein by avian liver cells in nonproliferating monolayer culture: Hormonal effects. J Cell Biol. 1977, 73, 332-353.
34. J. Girard, D. Perdereau, F. Foufelle, C. Prip-Buus, P. Ferré: Regulation of lipogenic enzyme gene expression by nutrients and hormones. FASEB J. 1994, 8, 36-42.
35. P. Lefevre, C. Diot, P. Legrand, M. Douaire: Hormonal regulation of stearoyl coenzyme-A desaturase 1 activity and gene expression in primary cultures of chicken hepatocytes. Arch Biochem Biophys. 1999, 368, 329-337.
36. C. R. Yellaturu, X. Deng, L. M. Cagen, H. G. Wilcox, E. A. Park, R. Raghow, M. B. Elam: Posttranslational processing of SREBP-1 in rat hepatocytes is regulated by insulin and cAMP. Biochem Biophys Res Commun. 2005, 332, 174-180.
37. M. Foretz, C. Pacot, I. Dugail, P. Lemarchand, C. Guichard, X. Le Lièpvre, C. Berthelier-Lubrano, B. Spiegelman, J. B. Kim, P. Ferré, F. Foufelle: ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose. Mol Cell Biol. 1999, 19, 3760-3768.
38. J. M. Yamada, T. Sakuma, T. Suga: Induction of peroxisomal beta-oxidation enzymes by dehydroepiandrosterone and its sulfate in primary cultures of rat hepatocytes. Biochim Biophys Acta. 1992, 1160, 231-236.
39. K. Schoonjans, B. Staels, J. Auwerx: The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta. 1996, 1302, 93-109.
40. J. R. Dyck, A. J. Barr, R. L. Barr, P. E. Kolattukudy, G. D. Lopaschuk: Characterization of cardiac malonyl-CoA decarboxylase and its putative role in regulating fatty acid oxidation. Am J Physiol. 1998, 275, 2122-2129.
41. G. Velasco, T. Gomez del Pulgar, D. Carling, M. Guzman: Evidence that the AMP-activated protein kinase stimulates rat liver carnitine palmitoyltransferase I by phosphorylating cytoskeletal components. FEBS Lett. 1998, 439, 317-320.
42. I. Issemann, S. Green: Activation of a number of the steroid receptor superfamily by peroxisome proliferators. Nature. 1990, 347, 645-650.
43. M. Gottlicher, E. Widmark, Q. Li, J. A. Gustafsson: Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc Natl Acad Sci USA. 1992, 89, 4653-4657.
44. C. Dreyer, G. Krey, H. Keller, F. Givel, G. Helftenbein, W. Wahli: Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell. 1992, 68, 879-887.
45. M. Bellei, D. Battelli, C. Fornieri, G. Mori, U. Muscatello, H. Lardy, V. Bobyleva: Changes in liver structure and function after short-term and long-term treatment of rats with dehydroepiandrosterone. J Nutr. 1992, 122, 967-976.
46. P. Buffa, V. Guarriera-Bobyleva, U. Muscatello, I. Pasquali-Ronchetti: Conformational changes of mitochondria associated with uncoupling of oxidative phosphorylation in vivo and in vitro. Nature. 1970, 226, 272-274.
47. V. Bobyleva-Guarriero, D. Ceccarelli-Stanzani, A. Masini, U. Muscatello: The relation between structural and metabolic steady-states in isolated rat liver mitochondria. A study of the functional significance. J Submicrosc Cytol. 1982, 14, 461-470.
48. A. Masini, V. Guarriero-Bobyleva, D. Ceccarelli, U. Muscatello: Configurational changes in isolated rat liver mitochondria: A possible functional significance. IRCS Med Sci. 1978, 6, 394.
49. M. R. Williams, S. Ling, T. Dawood, K. Hashimura, A. Dai, H. Li, J. P. Liu, J. W. Funder, K. Sudhir, P. A. Komesaroff: Dehydroepiandrosterone inhibits human vascular smooth muscle cell proliferation independent of ARs and ERs. J Clin Endocrinol Metab. 2002, 87, 176-181.
50. L. Zhang, B. Li, W. Ma, J. L. Barker, Y. H. Chang, W. Zhao, D. R. Rubinow: Dehydroepiandrosterone (DHEA) and its sulfated derivative (DHEAS) regulate apoptosis during neurogenesis by triggering the Akt signaling pathway in opposing ways. Brain Res Mol Brain Res. 2002, 98, 58-66.
51. 3H] DHEA binding in rat liver. Biochem Biophys Res Commun. 1988, 156, 22-29.
52. T. Mine: The role of dehydroepiandrosterone in apoptosis and proliferation and its relation to the phosphatidyl inositol-3-kinase/Akt signaling pathway. J Gastroenterol. 2005, 40, 553-554.
53. G. Kulik, M. J. Weber: Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor I. Mol Cell Biol. 1998, 18, 6711-6718.
54. Y. Jiang, T. Miyazaki, A. Honda, T. Hirayama, S. Yoshida, N. Tanaka, Y. Matsuzaki: Apoptosis and inhibition of the phosphatidylinositol 3-kinase/Akt signaling pathway in the antiproliferative actions of dehydroepiandrosterone. J Gastroenterol. 2005, 40, 490-497.
55. A. Bonni, A. Brunet, A. E. West, S. R. Datta, M. A. Takasu, M. E. Greenberg: Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 1999, 268, 1358-1362.
56. B. Zumoff, R. S. Rosenfeld, G. W. Strain: Sex differences in the twenty four hour mean plasma concentrations of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) and the DHEA to DHEAS ratio in normal adults. J Clin Endocrinol Metab. 1980, 51, 330-333.